Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Equity (2021 - 2025)

Historic Return on Equity for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to 1.4%.

  • Verrica Pharmaceuticals' Return on Equity fell 21900.0% to 1.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.4%, marking a year-over-year decrease of 21900.0%. This contributed to the annual value of 14.93% for FY2024, which is 126900.0% down from last year.
  • Per Verrica Pharmaceuticals' latest filing, its Return on Equity stood at 1.4% for Q3 2025, which was down 21900.0% from 2.6% recorded in Q2 2025.
  • Verrica Pharmaceuticals' Return on Equity's 5-year high stood at 14.74% during Q2 2024, with a 5-year trough of 7.59% in Q1 2024.
  • Its 5-year average for Return on Equity is 0.8%, with a median of 0.47% in 2022.
  • As far as peak fluctuations go, Verrica Pharmaceuticals' Return on Equity soared by 151000bps in 2024, and later crashed by -121400bps in 2025.
  • Verrica Pharmaceuticals' Return on Equity (Quarter) stood at 0.96% in 2021, then soared by 43bps to 0.54% in 2022, then crashed by -297bps to 2.16% in 2023, then soared by 256bps to 3.37% in 2024, then plummeted by -58bps to 1.4% in 2025.
  • Its last three reported values are 1.4% in Q3 2025, 2.6% for Q2 2025, and 4.47% during Q1 2025.